The beta-adrenergic antagonist propranolol partly abolishes thermogenic response to bioactive food ingredients

Anita Belza1, Maj-Britt Gille, Sarah Schultz John

  • 1Department of Human Nutrition, Centre for Advanced Food Studies, University of Copenhagen, DK-1958 Frederiksberg C, Denmark. anbe@life.ku.dk

Insights

A bioactive combination (BC) enhances thermogenesis, but propranolol significantly reduces this effect by 50%. This suggests beta-adrenergic pathways are crucial for the thermogenic response to BC.

Area of Science:

  • Human physiology
  • Pharmacology
  • Nutritional science

Background:

  • A combination of tyrosine, capsaicin, catechins, and caffeine (bioactive combination, BC) is known to increase thermogenesis.
  • The role of beta-adrenergic pathways in mediating this thermogenic response is not fully understood.

Purpose of the Study:

  • To investigate the effect of propranolol, a beta-adrenergic blocker, on the thermogenic response to the bioactive combination (BC).
  • To determine the involvement of beta-adrenergic pathways in the thermogenic effects of BC.

Main Methods:

  • A 4-way, randomized, double-blind, placebo-controlled crossover study involving 22 men.
  • Participants received placebo, BC, BC + 5 mg propranolol, or BC + 10 mg propranolol.
  • Measurements included resting metabolic rate, respiratory quotient, blood pressure, heart rate, and appetite ratings over 5 hours.

Main Results:

  • The BC significantly increased resting metabolic rate by 5% compared to placebo.
  • Both doses of propranolol blunted the thermogenic response to BC by 50%.
  • BC increased systolic and diastolic blood pressure; propranolol reduced the systolic effect but not the diastolic effect. Propranolol decreased heart rate.

Conclusions:

  • The study confirms the thermogenic properties of the bioactive combination (BC).
  • Beta-adrenergic pathways are partly responsible for the thermogenic response to BC, as evidenced by the 50% reduction in effect by propranolol.
  • The findings provide insight into the physiological mechanisms underlying the thermogenic effects of dietary compounds.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but nonselective agent, paving the way...
Thermoregulation01:26

Thermoregulation

The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...